Use of an inhibitor of the protein tyrosine kinase pathway in the treatment of choroidal neovascularization
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 22, 2000
Grant Date -
N/A
app pub date -
Mar 13, 1998
filing date -
Mar 13, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention is directed to a method for the prophylactic and therapeutic treatment of choroidal neovascularization. The method involves the administration of an inhibitor of the protein tyrosine kinase pathway to an animal, such as a mammal, in particular a human, in an amount sufficient to treat the choroid for neovascularization prophylactically or therapeutically. The inhibitor of the protein tyrosine kinase pathway is preferably genistein or an analogue or prodrug thereof or a pharmaceutically acceptable salt of any of the foregoing.
First Claim
Family
International Classification(s)
- No Non-US Classification to display
Cited Art Landscape
Patent Citation Ranking
- No Patent Citation Ranking to display
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully